Differential Reconstitution of T Cell Subsets following Immunodepleting Treatment with Alemtuzumab (Anti-CD52 Monoclonal Antibody) in Patients with Relapsing–Remitting Multiple Sclerosis
2013 ◽
Vol 191
(12)
◽
pp. 5867-5874
◽
2019 ◽
Vol 337
◽
pp. 577065
◽
2006 ◽
Vol 83
(8)
◽
pp. 1432-1446
◽
2000 ◽
Vol 6
(3)
◽
pp. 140-147
◽